The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 345:620-621 August 23, 2001 Number 8
NextNext

Atrial Fibrillation

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: In his review article on atrial fibrillation (April 5 issue),1 Falk suggests that patients admitted to the hospital with atrial fibrillation of less than 48 hours' duration should be treated differently from those with atrial fibrillation of more than 48 hours' duration. He suggests that all patients in whom spontaneous conversion to sinus rhythm does not occur should receive anticoagulation therapy with heparin; however, only those with atrial fibrillation of more than 48 hours' duration should undergo transesophageal-guided cardioversion to exclude the presence of atrial thrombi before cardioversion. Falk's suggestion perpetuates the myth that cardioversion of atrial . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.